CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 200 of 465 entries

View as:

Validation of Biomarkers of Exposure and Host Response

Phase: N/A Priority: Normal

NCT ID: NCT00468234 Org: User:

Start: 12/31/05 End: 09/30/07 Due: 09/30/08

Using Web-based Technology to Expand and Enhance Applied Behavioral Analysis Programs for Children With Autism in Military Families

Phase: N/A Priority: Normal

NCT ID: NCT01614275 Org: User:

Start: 05/30/12 End: 07/01/18 Due: 07/01/19

Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia

Phase: N/A Priority: Normal

NCT ID: NCT02647892 Org: User:

Start: 01/08/16 End: 11/05/21 Due: 11/05/22

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT04141995 Org: User:

Start: 02/12/21 End: 06/30/25 Due: 06/30/26

Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal

NCT ID: NCT00574509 Org: User:

Start: 03/04/96 End: 12/10/14 Due: 12/10/15

Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients

Phase: N/A Priority: Normal

NCT ID: NCT00672672 Org: User:

Start: 01/13/09 End: 01/06/10 Due: 01/06/11

Biomarker Assessments of Leukine During Treatment of Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT03790670 Org: User:

Start: 01/30/19 End: 10/01/24 Due: 10/01/25

Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction

Phase: N/A Priority: Normal

NCT ID: NCT00871637 Org: User:

Start: 08/01/08 End: 06/01/09 Due: 06/01/10

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Phase: N/A Priority: Normal

NCT ID: NCT00736450 Org: User:

Start: 07/23/08 End: 10/09/12 Due: 10/09/13

Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants

Phase: N/A Priority: Normal

NCT ID: NCT00580047 Org: User:

Start: 12/01/03 End: 07/29/14 Due: 07/29/15

Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis

Phase: N/A Priority: Normal

NCT ID: NCT00826020 Org: User:

Start: 05/01/09 End: 10/06/17 Due: 10/06/18

Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01093183 Org: User:

Start: 03/04/10 End: 05/19/15 Due: 05/19/16

A Study Utilizing Escitalopram in Glioma Patients

Phase: N/A Priority: Normal

NCT ID: NCT03728673 Org: User:

Start: 03/06/19 End: 08/31/27 Due: 08/31/28

Mechanisms That Produce the Leg Dysfunction of Claudication & Treatment Strategies

Phase: N/A Priority: Normal

NCT ID: NCT01970332 Org: User:

Start: 09/01/10 End: 05/30/16 Due: 05/30/17

Use of Reactivated DEFINITY or LUMASON in Patients Undergoing Rest or Stress Echocardiography

Phase: N/A Priority: Normal

NCT ID: NCT02950493 Org: User:

Start: 04/06/17 End: 09/30/24 Due: 09/30/25

First-Sight Refractive Error Correction in the Developing World

Phase: N/A Priority: Normal

NCT ID: NCT01598818 Org: User:

Start: 05/11/12 End: 01/13/14 Due: 01/13/15

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal

NCT ID: NCT02561273 Org: User:

Start: 09/28/15 End: 11/01/20 Due: 11/01/21

Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal

NCT ID: NCT00550615 Org: User:

Start: 09/17/07 End: 12/01/17 Due: 12/01/18

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00569543 Org: User:

Start: 05/11/05 End: 08/02/12 Due: 08/02/13

Talabostat in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00489710 Org: User:

Start: 12/31/06 End: 05/30/07 Due: 05/30/08

Quality End-of-Life Care in Nursing Homes

Phase: N/A Priority: Normal

NCT ID: NCT00616473 Org: User:

Start: 12/15/06 End: 01/01/11 Due: 01/01/12

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

Phase: N/A Priority: Normal

NCT ID: NCT05069038 Org: User:

Start: 03/02/22 End: 09/30/31 Due: 09/30/32

Mental Health Intervention for Black Fathers

Phase: N/A Priority: Normal

NCT ID: NCT03552783 Org: User:

Start: 03/08/19 End: 01/20/20 Due: 01/20/21

Hyaluronidase Via LADD Scleroderma-induced Microstomia

Phase: N/A Priority: Normal

NCT ID: NCT05995626 Org: User:

Start: 03/01/24 End: 09/24/24 Due: 09/24/25

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00611351 Org: User:

Start: 06/07/05 End: 09/17/08 Due: 09/17/09

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Validation of Biomarkers of Exposure and Host Response	NCT00468234	University of Nebraska	user2@example.com	None	2005-12-31	2007-09-30	2008-09-30	-	-	2025-07-14
Using Web-based Technology to Expand and Enhance Applied Behavioral Analysis Programs for Children With Autism in Military Families	NCT01614275	University of Nebraska	user2@example.com	None	2012-05-30	2018-07-01	2019-07-01	-	-	2025-07-14
Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia	NCT02647892	University of Nebraska	user2@example.com	None	2016-01-08	2021-11-05	2022-11-05	-	-	2025-07-14
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer	NCT04141995	University of Nebraska	user2@example.com	None	2021-02-12	2025-06-30	2026-06-30	-	-	2025-07-14
Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma	NCT00574509	University of Nebraska	user2@example.com	None	1996-03-04	2014-12-10	2015-12-10	-	-	2025-07-14
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients	NCT00672672	University of Nebraska	user2@example.com	None	2009-01-13	2010-01-06	2011-01-06	-	-	2025-07-14
Biomarker Assessments of Leukine During Treatment of Parkinson's Disease	NCT03790670	University of Nebraska	user2@example.com	None	2019-01-30	2024-10-01	2025-10-01	-	-	2025-07-14
Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction	NCT00871637	University of Nebraska	user2@example.com	None	2008-08-01	2009-06-01	2010-06-01	-	-	2025-07-14
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma	NCT00736450	University of Nebraska	user2@example.com	None	2008-07-23	2012-10-09	2013-10-09	-	-	2025-07-14
Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants	NCT00580047	University of Nebraska	user2@example.com	None	2003-12-01	2014-07-29	2015-07-29	-	-	2025-07-14
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis	NCT00826020	University of Nebraska	user2@example.com	None	2009-05-01	2017-10-06	2018-10-06	-	-	2025-07-14
Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer	NCT01093183	University of Nebraska	user2@example.com	None	2010-03-04	2015-05-19	2016-05-19	-	-	2025-07-14
A Study Utilizing Escitalopram in Glioma Patients	NCT03728673	University of Nebraska	user2@example.com	None	2019-03-06	2027-08-31	2028-08-31	-	-	2025-07-14
Mechanisms That Produce the Leg Dysfunction of Claudication & Treatment Strategies	NCT01970332	University of Nebraska	user2@example.com	None	2010-09-01	2016-05-30	2017-05-30	-	-	2025-07-14
Use of Reactivated DEFINITY or LUMASON in Patients Undergoing Rest or Stress Echocardiography	NCT02950493	University of Nebraska	user2@example.com	None	2017-04-06	2024-09-30	2025-09-30	-	-	2025-07-14
First-Sight Refractive Error Correction in the Developing World	NCT01598818	University of Nebraska	user2@example.com	None	2012-05-11	2014-01-13	2015-01-13	-	-	2025-07-14
Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma	NCT02561273	University of Nebraska	user2@example.com	None	2015-09-28	2020-11-01	2021-11-01	-	-	2025-07-14
Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma	NCT00550615	University of Nebraska	user2@example.com	None	2007-09-17	2017-12-01	2018-12-01	-	-	2025-07-14
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer	NCT00569543	University of Nebraska	user2@example.com	None	2005-05-11	2012-08-02	2013-08-02	-	-	2025-07-14
Talabostat in Treating Patients With Metastatic Kidney Cancer	NCT00489710	University of Nebraska	user2@example.com	None	2006-12-31	2007-05-30	2008-05-30	-	-	2025-07-14
Quality End-of-Life Care in Nursing Homes	NCT00616473	University of Nebraska	user2@example.com	None	2006-12-15	2011-01-01	2012-01-01	-	-	2025-07-14
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy	NCT05069038	University of Nebraska	user2@example.com	None	2022-03-02	2031-09-30	2032-09-30	-	-	2025-07-14
Mental Health Intervention for Black Fathers	NCT03552783	University of Nebraska	user2@example.com	None	2019-03-08	2020-01-20	2021-01-20	-	-	2025-07-14
Hyaluronidase Via LADD Scleroderma-induced Microstomia	NCT05995626	University of Nebraska	user2@example.com	None	2024-03-01	2024-09-24	2025-09-24	-	-	2025-07-14
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer	NCT00611351	University of Nebraska	user2@example.com	None	2005-06-07	2008-09-17	2009-09-17	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance